Cholera vaccine clinical trials: A cross-sectional analysis of clinical trials registries.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
08 2023
Historique:
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 27 9 2023
Statut: ppublish

Résumé

Cholera has been one of the world's biggest public health challenges for centuries. The presence of this disease brings into focus the social determinants of health in different parts of the world. Research and development efforts to find safe and effective Cholera vaccines are critical to decreasing the disease burden from

Identifiants

pubmed: 37759348
doi: 10.1080/21645515.2023.2261168
pmc: PMC10619520
doi:

Substances chimiques

Cholera Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2261168

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Vaccine. 2020 Feb 29;38 Suppl 1:A118-A126
pubmed: 31879125
J Infect Dis. 2013 Nov 1;208 Suppl 1:S8-14
pubmed: 24101650
Trials. 2021 Jul 21;22(1):472
pubmed: 34289892
Trop Med Health. 2021 Nov 24;49(1):93
pubmed: 34819175
EMBO Mol Med. 2014 May 06;6(6):708-20
pubmed: 24803000
J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S701-S709
pubmed: 34549788
Front Oncol. 2021 May 13;11:688755
pubmed: 34055652
Vaccines (Basel). 2020 Oct 14;8(4):
pubmed: 33066373
Am J Public Health. 2004 Mar;94(3):400-5
pubmed: 14998803
Trials. 2016 Feb 24;17(1):106
pubmed: 26907923
J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S742-S748
pubmed: 34453544
N Engl J Med. 2017 Jan 26;376(4):383-391
pubmed: 28121511
Pediatr Infect Dis J. 2006 Dec;25(12):1163-6
pubmed: 17133163
PLoS One. 2018 Mar 7;13(3):e0193088
pubmed: 29513684
Int J Equity Health. 2018 Mar 22;17(1):37
pubmed: 29566721
BMC Biol. 2010 Oct 04;8:129
pubmed: 20920375

Auteurs

Lindi Mathebula (L)

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.

Thobile Malinga (T)

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.

Mammekwa Mokgoro (M)

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.

Duduzile Ndwandwe (D)

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.

Charles S Wiysonge (CS)

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
Vaccine-Preventable Diseases Programme, World Health Organisation Regional Office for Africa, Brazzaville, Congo.

Glenda Gray (G)

Office of the President and CEO, South African Medical Research Council, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH